581 related articles for article (PubMed ID: 32111704)
1. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
[TBL] [Abstract][Full Text] [Related]
2. The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.
Bullen AL; Katz R; Lee AK; Anderson CAM; Cheung AK; Garimella PS; Jotwani V; Haley WE; Ishani A; Lash JP; Neyra JA; Punzi H; Rastogi A; Riessen E; Malhotra R; Parikh CR; Rocco MV; Wall BM; Bhatt UY; Shlipak MG; Ix JH; Estrella MM
Kidney Int; 2019 Aug; 96(2):470-479. PubMed ID: 31262489
[TBL] [Abstract][Full Text] [Related]
3. Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.
Miller LM; Rifkin D; Lee AK; Kurella Tamura M; Pajewski NM; Weiner DE; Al-Rousan T; Shlipak M; Ix JH
Am J Kidney Dis; 2021 Oct; 78(4):530-540.e1. PubMed ID: 33647393
[TBL] [Abstract][Full Text] [Related]
4. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ;
J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
[TBL] [Abstract][Full Text] [Related]
6. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
[TBL] [Abstract][Full Text] [Related]
7. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
[TBL] [Abstract][Full Text] [Related]
8. Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.
Nadkarni GN; Rao V; Ismail-Beigi F; Fonseca VA; Shah SV; Simonson MS; Cantley L; Devarajan P; Parikh CR; Coca SG
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1343-1352. PubMed ID: 27189318
[TBL] [Abstract][Full Text] [Related]
9. Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
Jotwani VK; Lee AK; Estrella MM; Katz R; Garimella PS; Malhotra R; Rifkin DE; Ambrosius W; Freedman BI; Cheung AK; Raphael KL; Drawz P; Neyra JA; Oparil S; Punzi H; Shlipak MG; Ix JH;
Am J Nephrol; 2019; 49(5):346-355. PubMed ID: 30939472
[TBL] [Abstract][Full Text] [Related]
10. Kidney tubule health, mineral metabolism and adverse events in persons with CKD in SPRINT.
Ascher SB; Scherzer R; Estrella MM; Berry JD; de Lemos JA; Jotwani VK; Garimella PS; Malhotra R; Bullen AL; Katz R; Ambrosius WT; Cheung AK; Chonchol M; Killeen AA; Ix JH; Shlipak MG;
Nephrol Dial Transplant; 2022 Aug; 37(9):1637-1646. PubMed ID: 34473302
[TBL] [Abstract][Full Text] [Related]
11. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.
Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Gonzalez MC; Coca S; Schrauben SJ; Waikar SS; Ramachandran VS; Shlipak MG; Warady B; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S;
J Am Soc Nephrol; 2020 May; 31(5):1067-1077. PubMed ID: 32234829
[TBL] [Abstract][Full Text] [Related]
12. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
[TBL] [Abstract][Full Text] [Related]
13. Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants.
Nadkarni GN; Chauhan K; Rao V; Ix JH; Shlipak MG; Parikh CR; Coca SG
Am J Kidney Dis; 2019 Jan; 73(1):31-38. PubMed ID: 30291011
[TBL] [Abstract][Full Text] [Related]
14. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
15. Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes.
Chen TK; Coca SG; Thiessen-Philbrook HR; Heerspink HJL; Obeid W; Ix JH; Fried LF; Bonventre JV; El-Khoury JM; Shlipak MG; Parikh CR;
Am J Nephrol; 2022; 53(11-12):775-785. PubMed ID: 36630924
[TBL] [Abstract][Full Text] [Related]
16. Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.
Jotwani V; Garimella PS; Katz R; Malhotra R; Bates J; Cheung AK; Chonchol M; Drawz PE; Freedman BI; Haley WE; Killeen AA; Punzi H; Sarnak MJ; Segal MS; Shlipak MG; Ix JH;
Am J Nephrol; 2020; 51(10):797-805. PubMed ID: 32906135
[TBL] [Abstract][Full Text] [Related]
17. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
Gutiérrez OM; Shlipak MG; Katz R; Waikar SS; Greenberg JH; Schrauben SJ; Coca S; Parikh CR; Vasan RS; Feldman HI; Kimmel PL; Cushman M; Bonventre JV; Sarnak MJ; Ix JH
Am J Kidney Dis; 2022 Jun; 79(6):849-857.e1. PubMed ID: 34752914
[TBL] [Abstract][Full Text] [Related]
18. Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.
Lee AK; Katz R; Jotwani V; Garimella PS; Ambrosius WT; Cheung AK; Gren LH; Neyra JA; Punzi H; Raphael KL; Shlipak MG; Ix JH
Hypertension; 2019 Oct; 74(4):872-879. PubMed ID: 31378102
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of inflammation and repair in kidney disease progression.
Puthumana J; Thiessen-Philbrook H; Xu L; Coca SG; Garg AX; Himmelfarb J; Bhatraju PK; Ikizler TA; Siew ED; Ware LB; Liu KD; Go AS; Kaufman JS; Kimmel PL; Chinchilli VM; Cantley LG; Parikh CR
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33290282
[TBL] [Abstract][Full Text] [Related]
20. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
Park M; Hsu CY; Go AS; Feldman HI; Xie D; Zhang X; Mifflin T; Waikar SS; Sabbisetti VS; Bonventre JV; Coresh J; Nelson RG; Kimmel PL; Kusek JW; Rahman M; Schelling JR; Vasan RS; Liu KD; ;
Clin J Am Soc Nephrol; 2017 May; 12(5):761-771. PubMed ID: 28254771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
